113 related articles for article (PubMed ID: 28790265)
1. [A Case of Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy].
Ito T; Deguchi K; Yoshii K; Kashii M
Gan To Kagaku Ryoho; 2017 Jul; 44(7):599-602. PubMed ID: 28790265
[TBL] [Abstract][Full Text] [Related]
2. [Cystoid macular edema secondary to albumin-bound paclitaxel therapy for pancreatic cancer].
Ota S; Tanke G; Ito R; Hara K; Takada Y; Adachi K; Shimada Y; Itani T
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(3):272-278. PubMed ID: 33692262
[TBL] [Abstract][Full Text] [Related]
3. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
Rahman HT; Yeh S; Bergstrom CS
J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
[TBL] [Abstract][Full Text] [Related]
4. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
5. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
Otsubo M; Kinouchi R; Kamiya T; Yoshida A
J Med Case Rep; 2021 Jul; 15(1):355. PubMed ID: 34284818
[TBL] [Abstract][Full Text] [Related]
6. Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.
Rahimy E; Sarraf D
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):187-9. PubMed ID: 23421925
[TBL] [Abstract][Full Text] [Related]
7. Nab-Paclitaxel related cystoid macular edema.
Di Pippo M; Di Staso F; De Ponte C; Fragiotta S; Abdolrahimzadeh S
Clin Ter; 2022; 173(4):377-383. PubMed ID: 35857057
[TBL] [Abstract][Full Text] [Related]
8. Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer.
Yamane H; Itagaki T; Kajitani K; Koura Y; Kawabuchi Y; Ohara M
Case Rep Oncol; 2023; 16(1):1121-1128. PubMed ID: 37900858
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review.
Ye S; Fang Q; Yao J; Xing J; Tang S; Ma JH
Front Oncol; 2021; 11():773540. PubMed ID: 34966680
[TBL] [Abstract][Full Text] [Related]
10. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
Park E; Goldberg NR; Adams S
Anticancer Drugs; 2016 Jul; 27(6):580-4. PubMed ID: 26982237
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima T; Kawajiri H; Nishimori T; Tei S; Nishimura S; Yamagata S; Tokunaga S; Mizuyama Y; Sunami T; Tezuka K; Ikeda K; Ogawa Y; Kashiwagi S; Noda S; Onoda N; Ishikawa T; Kudoh S; Takada M; Hirakawa K; Ohira M
Anticancer Res; 2018 Jan; 38(1):379-383. PubMed ID: 29277798
[TBL] [Abstract][Full Text] [Related]
12. Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema.
Lee J; Ra H; Baek J
Indian J Ophthalmol; 2019 Dec; 67(12):2058-2059. PubMed ID: 31755455
[No Abstract] [Full Text] [Related]
13. Macular Cystoid Edema Induced by Nab-Paclitaxel.
Alves Pereira S; Vale C; Moreira J; Sampaio F
Acta Med Port; 2022 Apr; 35(4):294-297. PubMed ID: 34287143
[TBL] [Abstract][Full Text] [Related]
14. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.
Tsuyuki S; Senda N; Kanng Y; Yamaguchi A; Yoshibayashi H; Kikawa Y; Katakami N; Kato H; Hashimoto T; Okuno T; Yamauchi A; Inamoto T
Breast Cancer Res Treat; 2016 Nov; 160(1):61-67. PubMed ID: 27620884
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
Zhang HR; Wang X; Lu XR; Yang YF; Liu F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
[TBL] [Abstract][Full Text] [Related]
17. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
18. Cystoid macular edema associated with chemotherapy.
Rao RC; Choudhry N
CMAJ; 2016 Feb; 188(3):216. PubMed ID: 26243822
[No Abstract] [Full Text] [Related]
19. A case of cystoid macular edema associated with Paclitaxel chemotherapy.
Ham DS; Lee JE; Kim HW; Yun IH
Korean J Ophthalmol; 2012 Oct; 26(5):388-90. PubMed ID: 23060727
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
Matsui A; Tatibana A; Suzuki N; Hirata M; Oishi Y; Hamaguchi Y; Murata Y; Nagayama A; Iwata Y; Okamoto Y
Anticancer Res; 2017 Nov; 37(11):6481-6488. PubMed ID: 29061836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
